LORDS MARK INDUSTRIES SETS OUT TO MAKE INDIA A MEDTECH POWERHOUSE

In a world where healthcare challenges are increasingly complex, the demand for affordable, accessible, and innovative solutions has never been greater. At the forefront of this transformation in India is Lords Mark Industries Ltd. (LMIL), a diversified business group that has steadily risen to become one of the country's most ambitious players in MedTech, diagnostics, biotechnology, and renewable energy.

- 

What began in 1998 as a modest venture is today a global enterprise with a bold outlook. LMIL is not just expanding its footprint but is also actively reshaping how healthcare innovation can be scaled to serve millions, in India and beyond.

Healthcare has increasingly become the company's defining focus. In a nation grappling with a rising burden of lifestyle disorders and chronic diseases, LMIL has chosen to concentrate its resources on areas that combine technological progress with meaningful social impact. Among its most notable initiatives is Renalyx, a comprehensive World first Al-based Indigenous Smart Dialysis kidney care ecosystem that integrates early screening strips, an Al-powered dialysis machine designed for rural accessibility, and a nationwide analytics platform to track chronic kidney disease. Alongside this stands One DNA, a genomics platform that gives individuals insights into predispositions for cardiac disease, cancer, and lifestyle disorders, shifting the healthcare model from reactive treatment to proactive prevention.

The collaboration between IIT-B and Lords Mark Industries aims to revolutionize sickle cell testing in India, providing improved disease diagnosis and management for patients across the country at the point of primary care, thereby reducing costs and enabling convenience for the affected population.

Equally forward-looking is the company's proactive approach to cancer prevention by identifying predispositions and facilitating early detection of more than 15 cancer types and their causative traits – bringing advanced science and technology into everyday healthcare.

Together, these initiatives embody the company's philosophy that care must be affordable, accurate, and accessible to all – whether in a high-end metropolitan hospital or a small-town clinic.